Frontiers in microbiology · 2026
Cyclic lipopeptides from Bacillus amyloliquefaciens D-1 control leaf spot in Pseudostellaria heterophylla via enhancing host immunity and inhibiting Alternaria alternata.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Shi Haixia, Zhou Shihua, Gao Yanping, Jiang Xue, Qin Lang, Wang Lingling, Ou Xiaohong, Wang Yanhong, Guo Lanping, Gu Li, Yuan Qing-Song, Zhou Tao
Аннотация
INTRODUCTION: Pseudostellaria heterophylla, a valuable medicinal herb in traditional Chinese medicine, is severely threatened by leaf spot disease caused by Alternaria alternata, leading to significant yield losses and mycotoxin contamination that compromises root quality and safety. This study aimed to characterize Bacillus amyloliquefaciens strain D-1 as a potential multifunctional biocontrol agent to mitigate this pathogen.
METHODS: Strain D-1 was isolated from the rhizosphere soil of P. heterophylla. Its antifungal efficacy was assessed through in vitro dual-culture assays and in planta pot experiments using both viable cells (Bc) and cell-free fermentation supernatant (Bf). Whole-genome sequencing was employed to identify biosynthetic gene clusters (BGCs), and high-performance liquid chromatography-mass spectrometry (HPLC-MS) was used to detect lipopeptides (LPs). Quantitative PCR and mycotoxin quantification were performed to evaluate the effects on fungal gene expression and toxin accumulation.
RESULTS: Strain D-1 demonstrated strong antagonistic activity, with Bf achieving a 54.7% inhibition rate against A. alternata. Genomic analysis revealed nine putative BGCs, including those for fengycin, iturin, and surfactin. HPLC-MS confirmed the production of these LPs, which effectively disrupted hyphal branching and spore germination. In pot trials, crude LP extracts reduced disease lesion area by 92.0% and suppressed key mycotoxin biosynthesis genes (PKSJ, PKSA, etc.), leading to a 77.0-98.1% reduction in toxin levels (ALT, AME, TeA, TEN). Additionally, strain D-1 and its LPs triggered systemic resistance in P. heterophylla, evidenced by elevated H₂O₂ accumulation and callose deposition.
DISCUSSION: The findings establish B. amyloliquefaciens D-1 as a novel biocontrol agent with triple mechanisms: direct antifungal action, suppression of mycotoxin biosynthesis, and induction of host systemic resistance. Its application offers a sustainable strategy to manage A. alternata in P. heterophylla cultivation, addressing both disease control and medicinal safety concerns. heterophylla cultivation, addressing both disease control and medicinal safety concerns.
METHODS: Strain D-1 was isolated from the rhizosphere soil of P. heterophylla. Its antifungal efficacy was assessed through in vitro dual-culture assays and in planta pot experiments using both viable cells (Bc) and cell-free fermentation supernatant (Bf). Whole-genome sequencing was employed to identify biosynthetic gene clusters (BGCs), and high-performance liquid chromatography-mass spectrometry (HPLC-MS) was used to detect lipopeptides (LPs). Quantitative PCR and mycotoxin quantification were performed to evaluate the effects on fungal gene expression and toxin accumulation.
RESULTS: Strain D-1 demonstrated strong antagonistic activity, with Bf achieving a 54.7% inhibition rate against A. alternata. Genomic analysis revealed nine putative BGCs, including those for fengycin, iturin, and surfactin. HPLC-MS confirmed the production of these LPs, which effectively disrupted hyphal branching and spore germination. In pot trials, crude LP extracts reduced disease lesion area by 92.0% and suppressed key mycotoxin biosynthesis genes (PKSJ, PKSA, etc.), leading to a 77.0-98.1% reduction in toxin levels (ALT, AME, TeA, TEN). Additionally, strain D-1 and its LPs triggered systemic resistance in P. heterophylla, evidenced by elevated H₂O₂ accumulation and callose deposition.
DISCUSSION: The findings establish B. amyloliquefaciens D-1 as a novel biocontrol agent with triple mechanisms: direct antifungal action, suppression of mycotoxin biosynthesis, and induction of host systemic resistance. Its application offers a sustainable strategy to manage A. alternata in P. heterophylla cultivation, addressing both disease control and medicinal safety concerns. heterophylla cultivation, addressing both disease control and medicinal safety concerns.